Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Vaccination Coverage Teens 2008 Table

This website is archived for historical purposes and is no longer being maintained or updated.

August 25, 2011: Content on this page kept for historical reasons.

Estimated Vaccination Coverage With Selected Vaccines Among Adolescents Aged 13-17* Years by Age at Interview
-- National Immunization Survey-Teen, United States, 2008
 Age at Interview (years)  
Vaccines13
n = 3,455
% (95% CI)
14
n = 3,641
% (95% CI)
15
n = 3,666
% (95% CI)
16
n = 3,731
% (95% CI)
17
n = 3,342
% (95% CI)
 2008
n = 17,835
% (95% CI)
MMR§  ≥ 2 doses90.3 (88.0-92.2)91.8 (89.8-93.4)90.1 (88.1-91.8)86.2 (83.7-88.4)88.1 (86.1-89.9) 89.3 (88.4-90.2)
Hepatitis B ≥ 3 doses92.8 (91.1-94.1)93.1 (91.5-94.3)89.6 (87.0-91.7)81.5 (78.6-84.1)82.9 (80.7-84.8) 87.9 (86.9-88.8)
Varicella 
History of varicella   disease¶ 42.3 (39.2-45.5)50.1 (46.9-53.3)62.8 (59.5-66.0)68.2 (65.1-71.2)74.8 (71.3-78.1) 59.8 (58.4-61.3)
 ≥ 1 dose vaccine if had no history of disease89.6 (87.1-91.6)85.2 (81.6-88.3)80.2 (75.2-84.4)76.5 (71.8-80.6)68.2 (61.7-74.1) 81.9 (80.2-83.6)
 ≥ 2 doses vaccine if had no history of disease40.5 (36.4-44.8)34.5 (30.1-39.1)34.2 (29.1-39.7)28.1 (22.9-33.9)26.9 (18.9-36.7) 34.1 (31.8-36.5)
History of disease or received ≥ 1 dose varicella vaccination94.0 (92.5-95.2)92.6 (90.7-94.2)92.6 (90.5-94.3)92.5 (91.0-93.8)92.0 (90.5-93.3) 92.7 (92.0-93.4)
Td or Tdap since age 10 years** 
≥ 1 dose Td or Tdap64.1 (61.0-67.2)69.7 (66.5-72.7)77.7 (75.2-80.0)74.8 (71.9-77.5)73.7 (70.7-76.6) 72.2 (70.8-73.4)
≥ 1 dose Tdap 51.9 (48.7-55.1)47.3 (44.0-50.5)41.5 (38.1-44.9)35.1 (32.1-38.1)28.7 (25.5-32.1) 40.8 (39.3-42.2)
MCV4§§  ≥1 dose42.0 (38.8-45.1)43.0 (39.9-46.3)46.4 (43.0-49.7)40.5 (37.4-43.6)36.7 (33.5-40.0) 41.8 (40.3-43.2)
HPV4¶¶   
  ≥ 1 dose35.2 (31.1-39.6)33.8 (29.5-38.3)42.2 (37.5-47.2)35.7 (31.7-39.9)38.5 (33.3-43.9) 37.2 (35.1-39.3)
  ≥ 3 doses14.5 (11.9-17.5)16.6 (13.5-20.2)18.5 (15.5-21.8)18.8 (15.6-22.4)20.9 (16.3-26.3) 17.9 (16.3-19.6)

* Adolescents in the 2008 NIS-Teen were born during January 1990-February 1996.

State estimate presented as point estimate (%) ± 95% confidence interval (CI).

§ Measles, mumps, and rubella vaccine.

By parent/guardian report or provider records.

** Includes percentages receiving tetanus and diptheria toxoid vaccine (Td), tetanus toxoid, reduced diptheria toxid, and acellular pertussis (Tdap), or tetanus-unknown type vaccine.

§§ Includes percentages receiving meningococcal conjugate vaccine (MCV4) or meningococcal-unknown type vaccine.

¶¶Quadrivalent human papillomavirus vaccine. Percentages reported among females only (n=8,607); HPV4 vaccine is not recommended for males.

 Top of Page

Top